Aurobindo Pharma rose 2.69% to Rs 1029 after the company’s consolidated net profit surged 90.6% to Rs 936 crore in Q3 FY24 as compared with Rs 491 crore in Q3 FY23.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Aurobindo Pharma rose 2.69% to Rs 1029 after the company’s consolidated net profit surged 90.6% to Rs 936 crore in Q3 FY24 as compared with Rs 491 crore in Q3 FY23.
| Subscribe To Our Free Newsletter |
